Table 2.
Clinical and Behavioral characteristics of HIV positive patients accessing ART at Health centers in East Gojjam Zone, Northwest Ethiopia, 2019.
Variables | Frequency | Percentages | |
---|---|---|---|
Most recent HIV stage | Stage I | 278 | 36.3 |
Stage II | 293 | 38.3 | |
Stage III | 173 | 22.6 | |
Stage IV | 21 | 2.7 | |
ARV drug used | TDF+3 TC + EFV | 286 | 37.4 |
AZT+3 TC + EFV | 229 | 29.9 | |
AZT+3 TC + NVP | 99 | 12.9 | |
TDF+3 TC + NVP | 90 | 11.8 | |
ABC+3 TC + EFV | 61 | 8.0 | |
Most recent CD4 Cell count | <200 | 116 | 15.2 |
200–500 | 315 | 41.2 | |
501–800 | 240 | 31.4 | |
>800 | 94 | 12.3 | |
History of opportunistic infections (OIs) | Yes | 415 | 54.2 |
No | 350 | 45.8 | |
Experienced side effects | Yes | 342 | 44.7 |
No | 423 | 55.3 | |
Duration of Disease | <1 Year | 80 | 10.5 |
1–5 Year | 376 | 49.2 | |
6–10 Year | 241 | 31.5 | |
>10 Year | 68 | 8.9 | |
Family disclosure status | Yes | 463 | 60.5 |
No | 302 | 39.5 | |
Family/social support | Yes | 412 | 53.9 |
No | 353 | 46.1 | |
Depressed | Yes | 346 | 45.2 |
No | 419 | 54.8 | |
Perceived social stigma | Yes | 318 | 41.6 |
No | 447 | 58.4 | |
Current substance use | Yes | 338 | 44.2 |
No | 427 | 55.8 | |
Adherence counseling | Yes | 461 | 60.3 |
No | 304 | 39.7 |